Xie F - Search Results

1

An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis.

Awad AM, Ntoso A, Connaire JJ, Hernandez GT, Dhillon K, Rich L, Henderson H, Lynn R, Hyer RN, Xie F, Erby K, Janssen RS; HBV-24 Study Group. Awad AM, et al. Among authors: xie f. Vaccine. 2021 Jun 8;39(25):3346-3352. doi: 10.1016/j.vaccine.2021.05.003. Epub 2021 May 14. Vaccine. 2021. PMID: 34001345 Free article. Clinical Trial.

2

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults.

Joines RW, Blatter M, Abraham B, Xie F, De Clercq N, Baine Y, Reisinger KS, Kuhnen A, Parenti DL. Joines RW, et al. Among authors: xie f. Vaccine. 2001 Sep 14;19(32):4710-9. doi: 10.1016/s0264-410x(01)00240-7. Vaccine. 2001. PMID: 11535321 Clinical Trial.

3

Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety.

Beran J, Xie F, Zent O. Beran J, et al. Among authors: xie f. Vaccine. 2014 Jul 23;32(34):4275-80. doi: 10.1016/j.vaccine.2014.06.028. Epub 2014 Jun 17. Vaccine. 2014. PMID: 24950352 Clinical Trial.

4

Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.

Girndt M, Houser P, Manllo-Karim R, Ervin JE, Charytan C, Chow S, Symonian-Silver M, Lehrner L, Linfert D, Shemin D, Michelsen A, Xie F, Janssen RS. Girndt M, et al. Among authors: xie f. Vaccine. 2023 May 11;41(20):3224-3232. doi: 10.1016/j.vaccine.2023.04.028. Epub 2023 Apr 19. Vaccine. 2023. PMID: 37085451 Free article. Clinical Trial.

5

Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents.

Richmond P, Nolan T, McGirr A, Napier-Flood F, Kim J, Leah A, Xie F, Campbell JD, Godeaux O, Henry O, Wood N, Janssen RS. Richmond P, et al. Among authors: xie f. Vaccine. 2024 Oct 24;42(24):126251. doi: 10.1016/j.vaccine.2024.126251. Epub 2024 Sep 2. Vaccine. 2024. PMID: 39226786 Clinical Trial.

6

Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination.

Block SL, Christensen S, Verma B, Xie F, Keshavan P, Dull PM, Smolenov I. Block SL, et al. Among authors: xie f. Vaccine. 2015 Apr 27;33(18):2175-82. doi: 10.1016/j.vaccine.2015.02.049. Epub 2015 Mar 2. Vaccine. 2015. PMID: 25744224 Clinical Trial.

7

Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.

Beran J, Lattanzi M, Xie F, Moraschini L, Galgani I. Beran J, et al. Among authors: xie f. Vaccine. 2019 Jul 26;37(32):4623-4629. doi: 10.1016/j.vaccine.2017.12.081. Epub 2018 Feb 1. Vaccine. 2019. PMID: 29397225 Free article. Clinical Trial.

8

Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label Trial.

Block SL, Shepard J, Garfield H, Xie F, Han L, Dull PM, Smolenov I. Block SL, et al. Among authors: xie f. Pediatr Infect Dis J. 2016 Feb;35(2):e48-59. doi: 10.1097/INF.0000000000000965. Pediatr Infect Dis J. 2016. PMID: 26479973 Clinical Trial.

9

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).

Esposito S, Prymula R, Zuccotti GV, Xie F, Barone M, Dull PM, Toneatto D. Esposito S, et al. Among authors: xie f. Hum Vaccin Immunother. 2014;10(7):2005-14. doi: 10.4161/hv.29218. Hum Vaccin Immunother. 2014. PMID: 25424810 Free PMC article. Clinical Trial.

10

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).

Prymula R, Esposito S, Zuccotti GV, Xie F, Toneatto D, Kohl I, Dull PM. Prymula R, et al. Among authors: xie f. Hum Vaccin Immunother. 2014;10(7):1993-2004. doi: 10.4161/hv.28666. Hum Vaccin Immunother. 2014. PMID: 25424809 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,544 results

Search Page

Filters